When the Prescriber Goes Quiet: A Practical Plan for Private GLP-1 Patients Facing Clinic Closure

The private weight-loss sector has expanded quickly, and consolidation has come with it. Clinics merge, pharmacies change hands and small online providers quietly stop taking new patients. For most people, this is a minor inconvenience. For a patient midway through GLP-1 treatment, it can feel considerably more serious: a repeat prescription fails to arrive, the website goes down and the only contact address bounces.

A clinic closure is not, in itself, a medical emergency. It is, however, an administrative problem that needs to be handled in a set order. The aim is to preserve your treatment history, avoid an unmonitored gap and move to a new prescriber with as little disruption as possible.

What a Closing Clinic Looks Like

Closure rarely arrives as a formal announcement. More often, patients notice that repeat prescription requests go unanswered, that the customer service phone line has been discontinued, or that the portal no longer accepts new orders. Sometimes a message appears stating that the service has been acquired by another company, with little detail about what happens to existing patients.

In other cases, a provider may pause prescribing temporarily while it reviews its clinical model or supply arrangements. A pause is not the same as closure, but it should be treated with the same practical caution: confirm in writing what is happening, when prescribing will resume and how your next dose will be supplied.

Warning Signs Worth Heeding Before You Pay

Most patients choose a private clinic because the NHS pathway is slow or because they do not meet its criteria. That is a legitimate choice, but it places a premium on checking who is actually responsible for your care.

Before paying any provider, confirm four things. First, that the prescriber is a registered healthcare professional and that the pharmacy dispensing your medicine is registered with the General Pharmaceutical Council. Second, that the clinic has a named clinical lead and a published address, not merely a contact form. Third, that it explains how it will share information with your GP, subject to your consent. Fourth, that its terms and conditions set out what happens to your records if the service closes.

Be cautious of prices that sit far below the market, of pressure to buy several months in advance, and of any site that cannot tell you which pharmacy will dispense your prescription. These are not proof of misconduct, but they are markers of a fragile operation.

Secure Your Medical Records First

Your treatment record is the single most useful thing you can take from a closing provider. Under UK data protection law, you have a right of access to your personal data, including clinical notes, dose history and correspondence. A subject access request should normally be answered within one month and, in most cases, free of charge.

Write to the provider using the email address in its privacy notice, and copy any clinical contact you have. Ask specifically for your prescription history, the dates and doses of each GLP-1 medicine, any recorded adverse effects, relevant blood test results and your starting and current weight. Keep the request factual and retain a copy.

If the website has gone down, try the company's registered address from Companies House. If the provider has been taken over, ask the new operator whether it holds the records and how to request them. Do not rely on the new clinic to volunteer this information.

You should also keep your own simple log: the medicine, the dose, the injection day and any side effects. It takes a few minutes each week and is invaluable if records are delayed.

Do Not Let Treatment Lapse Unmanaged

Stopping GLP-1 treatment abruptly is not comparable to stopping a medicine such as insulin, but it is not neutral either. Appetite usually returns, and some patients find that weight regain begins within weeks. Gastrointestinal effects may settle, but they can also recur if treatment is restarted later at the previous dose. Restarting without clinical advice is therefore unwise.

If you cannot obtain a repeat prescription, speak to a community pharmacist, your GP or NHS 111 for advice on what to do next. Do not double your remaining doses to compensate, and do not order from an unverified website or social media seller. Counterfeit and unauthorised GLP-1 products have been identified in the UK supply chain, and the MHRA has issued repeated warnings about pens obtained outside the regulated route.

Transferring to a New Prescriber Without Guesswork

When you approach a new provider, present the transfer as a clinical handover rather than a fresh start. Supply your dose history, your last injection date and any side effects you have experienced. Ask whether the new prescriber will contact your previous clinician, and confirm that the dispensing pharmacy is registered with the General Pharmaceutical Council.

Expect the new prescriber to verify your identity and your treatment history before issuing a prescription. A provider that offers to continue your existing dose immediately, without asking for records or a consultation, is not necessarily acting safely. Continuity is important, but so is confirming that the dose remains appropriate.

If you are transferring because of a closure, ask the new clinic to note this in your record. It is relevant to any future discussion about supply problems or missed doses.

If Supply Cannot Be Restored Quickly

In the short term, the priority is to avoid unsafe sourcing and to keep your GP informed. Your GP may not prescribe GLP-1 treatment for weight loss, but they should know what you have been taking. If you develop severe abdominal pain, persistent vomiting or signs of dehydration, seek urgent NHS advice rather than waiting for the clinic to respond.

Money, Complaints and Reporting

If you have paid for treatment that will not be supplied, ask the provider in writing for a refund. If payment was made by credit card and the amount exceeded £100, Section 75 of the Consumer Credit Act may apply; debit card payments may be eligible for a chargeback through your bank. Keep invoices and correspondence.

Complaints about a pharmacy should go to the General Pharmaceutical Council. Concerns about a clinic's data handling can be raised with the Information Commissioner's Office, and consumer issues can be reported to Trading Standards through Citizens Advice.

A Short Precautionary Checklist

• Keep a personal log of doses, dates and side effects.
• Save your provider's privacy notice and terms before they disappear.
• Request your full clinical record in writing.
• Confirm the registration status of any new pharmacy and prescriber.
• Never restart at a previous dose without advice.
• Report undelivered goods promptly to your card provider.

The closure of a private clinic is unsettling, but it is manageable. Records, a planned transfer and a refusal to improvise with supply will usually see patients through. The wider lesson is that choice in private care should be exercised with the same attention to accountability that one would expect from any regulated health service.